Minor CannabinoidNon-Psychoactive

CBG (Cannabigerol) | Cannabinoid Guide

Complete Guide to CBG in Medical Cannabis

Pronounced: see-bee-JEE

CBG (Cannabigerol) is a non-psychoactive minor cannabinoid. Learn about CBG (cannabigerol), the precursor to all cannabinoids. Discover its unique properties, potential benefits, and emerging research..

Boiling Point

126°F (52°C)

Formula

C₂₁H₃₂O₂

Legal Status

Legal federally when derived from hemp; not scheduled

Research Sources

5 peer-reviewed studies

Verified Via

PubMed / DOI

Evidence

Research-Backed

Updated

February 2026

Every claim cites peer-reviewed research
How We Research

What is CBG?

CBG (cannabigerol) is often called the "mother of all cannabinoids" because it's the precursor from which all other cannabinoids are synthesized. While typically present in low concentrations (<1%) in mature cannabis, specialized CBG-dominant strains are now being cultivated for research and therapeutic applications.

How CBG Works

CBG interacts with both CB1 and CB2 receptors, though with lower affinity than THC. It also acts on alpha-2 adrenergic receptors (which may explain potential anti-inflammatory effects), 5-HT1A serotonin receptors, and TRPM8 channels involved in pain perception.

Researched Effects

Anti-inflammatory

Emerging Research

Preclinical studies show promise for inflammatory bowel disease.

✓ Compliant Language

Early research suggests anti-inflammatory potential

✗ Avoid Saying

Treats IBD or inflammation

Neuroprotection

Emerging Research

Animal studies show potential protective effects on neural tissue.

✓ Compliant Language

Being researched for neuroprotective properties

✗ Avoid Saying

Protects the brain or treats neurological diseases

Antibacterial

Moderate Evidence

Shows activity against antibiotic-resistant bacteria including MRSA.

✓ Compliant Language

Demonstrates antibacterial properties in lab studies

✗ Avoid Saying

Treats infections

Medical Applications

Inflammatory Bowel Disease

Emerging Research

Preclinical studies show reduced inflammation in colitis models.

Glaucoma

Emerging Research

May reduce intraocular pressure; research ongoing.

Dosing Guidance

Limited human dosing data available. Most CBG products contain 10-50mg per serving. As a non-psychoactive cannabinoid, it's generally considered safe at moderate doses.

Safety Information

CBG appears to be well-tolerated in limited human studies. No significant adverse effects have been reported at typical doses. More research is needed on long-term safety.

Potential Side Effects

  • Limited data available
  • May cause drowsiness
  • Dry mouth possible
  • Appetite changes possible

Drug Interactions

Potential interactions not well-studied. May inhibit CYP450 enzymes similarly to CBD. Consult physician if taking other medications.

Scientific References

5 peer-reviewed sources cited

Research Methodology
  1. 1

    Nachnani R, et al. The Pharmacological Case for Cannabigerol Journal of Pharmacology and Experimental Therapeutics. 2021

    Most comprehensive CBG pharmacology review to date.

  2. 2

    Borrelli F, et al. Beneficial effect of cannabigerol on experimental inflammatory bowel disease Biochemical Pharmacology. 2013

    CBG reduced colitis markers in mouse IBD models.

  3. 3

    Valdeolivas S, et al. Neuroprotective properties of cannabigerol in Huntington's disease Neurotherapeutics. 2015

    CBG improved motor deficits in HD mouse models.

  4. 4

    Appendino G, et al. Antibacterial cannabinoids from Cannabis sativa Journal of Natural Products. 2008

    CBG showed potent activity against MRSA.

  5. 5

    Colasanti BK. A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol Journal of Ocular Pharmacology. 1990

    CBG reduced intraocular pressure in cat models.

Research Verification

All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.

Frequently Asked Questions

What is CBG?

CBG (cannabigerol) is a non-psychoactive cannabinoid often called the "mother of all cannabinoids" because it's the precursor from which THC, CBD, and other cannabinoids are synthesized.

Does CBG get you high?

No. CBG is non-psychoactive and does not produce intoxication. It interacts with cannabinoid receptors differently than THC.

What is CBG used for?

CBG is being researched for potential anti-inflammatory, antibacterial, and neuroprotective properties. It's available in oils, capsules, and CBG-dominant hemp strains.

Quick Facts

Full Name
Cannabigerol
Category
minor Cannabinoid
Psychoactive
No
Boiling Point
126°F (52°C)
Formula
C₂₁H₃₂O₂

Want to explore CBG products? Get your medical marijuana card today.

Get Your Card

Medical Disclaimer

This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.

Individual Variation

Cannabis affects everyone differently based on genetics, tolerance, and other factors. What works for one person may not work for another.

Start Low, Go Slow

Always begin with the lowest effective dose and increase gradually to minimize risk of adverse effects.